American Association of Nurse Anesthetists (AANA)

Survey Results Detail Signs of Improving Conditions for CRNAs

Newswise — PARK RIDGE, Ill. (AANA)—The American Association of Nurse Anesthetists (AANA) discovered in a new survey that employment opportunities for Certified Registered Nurse Anesthetists (CRNAs) during the COVID-19 public health crisis is improving, along with access to personal protective equipment (PPE) and the supply of drugs necessary for live-saving procedures.

“As multiple states across the country continue to struggle with higher infection rates and medical facilities reaching capacity, CRNAs continue to bring the life-sustaining skills needed to care for the nation’s critically ill patients,” said Lorraine Jordan, PhD, CRNA, CAE, FAAN, AANA chief advocacy officer. “Given CRNAs’ expertise in airway and ventilation management, CRNAs are uniquely positioned to support the U.S. healthcare system in dealing with the ongoing effects of the COVID-19 pandemic in the most effective and safest way possible.”

While an earlier survey of CRNAs indicated the pandemic has had a negative impact on their employment, new survey results show that CRNAs largely anticipate these impacts as temporary. With elective surgeries beginning to resume across the country, the survey found that overall, 70.4 percent of responding adversely impacted CRNAs anticipate increased hours or a return to previous employment. The survey also addressed preparation for the resumption of elective procedures, clinical practice challenges (caring for COVID-19 patients), potential shortages in PPE including the reuse of N95 masks, and potential shortages of anesthesia and pain medications. 

The AANA-led survey, which examined the impact of the pandemic to CRNAs before mid-May, found substantially fewer respondents reporting PPE shortages/outages compared to a first survey distributed in March. In the first survey, 72.8 percent of respondents reported a shortage of N95 masks, dropping to only 49.1 percent in the second survey with similar declines for most other PPE items. Additionally, 21.6 percent of responding CRNAs reported a shortage of anesthesia, sedation, or pain medications in their facilities.




Filters close

Showing results

110 of 3327
Newswise: How to Keep Children Safe from COVID-19 this Fall
Released: 18-Sep-2020 4:15 PM EDT
How to Keep Children Safe from COVID-19 this Fall
Rush University Medical Center

With the new school year started and autumn approaching, Colleen Nash, MD, MPH, Rush University Medical Center, pediatric infectious disease specialist, answers questions parents may have about keeping children safe from COVID, social distancing in the classroom and celebrating Halloween.

Released: 18-Sep-2020 4:05 PM EDT
Claims circulating on social media stating that the common cold or flu can be mistaken for COVID-19 are misleading
Newswise

The claims rely on the faulty assumption that there is no method to distinguish COVID-19 from the common cold and the flu.

Released: 18-Sep-2020 3:35 PM EDT
After developing CRISPR test, UConn researchers validate clinical feasibility for COVID-19 testing
University of Connecticut

In March, researchers in the Department of Biomedical Engineering-- a shared department in the schools of Dental Medicine, Medicine, and Engineering--began to develop a new, low-cost, CRISPR-based diagnostic platform to detect infectious diseases, including HIV virus, the novel coronavirus (SARS-CoV-2).

Newswise:Video Embedded blowin-in-the-wind
VIDEO
Released: 18-Sep-2020 3:10 PM EDT
Blowin' in the wind
University of Utah

University of Utah chemical engineers have conducted an air flow study of the venue that the Utah Symphony performs in to determine the best ways to mitigate the spread of COVID-19 through the emissions of wind instrument players.

Newswise: holman1_toned-1-768x512.jpg
Released: 18-Sep-2020 2:50 PM EDT
Study links rising stress, depression in U.S. to pandemic-related losses, media consumption
University of California, Irvine

Irvine, Calif., Sept. 18, 2020 – Experiencing multiple stressors triggered by the COVID-19 pandemic – such as unemployment – and COVID-19-related media consumption are directly linked to rising acute stress and depressive symptoms across the U.S., according to a groundbreaking University of California, Irvine study. The report appears in Science Advances, published by the American Association for the Advancement of Science.

Newswise: 243389_web.jpg
Released: 18-Sep-2020 10:55 AM EDT
Potential new drug to mitigate SARS-CoV-2 infection consequences
University of Malaga

Scientists from the Department of Cell Biology of the University of Malaga (UMA) and the Andalusian Centre for Nanomedicine and Biotechnology (BIONAND) have made progress in finding new rapid implementation therapies to combat the COVID-19 pandemic, identifying a new drug that could prevent or mitigate the consequences derived from SARS-CoV-2 infection.

Newswise: 243400_web.jpg
Released: 18-Sep-2020 10:40 AM EDT
Most homemade masks are doing a great job, even when we sneeze, study finds
University of Illinois at Urbana-Champaign

Studies indicate that homemade masks help combat the spread of viruses like COVID-19 when combined with frequent hand-washing and physical distancing.

access_time Embargo lifts in 2 days
Embargo will expire: 23-Sep-2020 8:00 AM EDT Released to reporters: 18-Sep-2020 10:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 23-Sep-2020 8:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 18-Sep-2020 8:30 AM EDT
Immunotherapy Drug Development Pipeline Continues Significant Growth in 2020 Despite Global Pandemic Impact
Cancer Research Institute

Despite the impact of the COVID-19 pandemic across the globe, there has been a resurgence of interest in immuno-oncology (I-O) preclinical and clinical development, bringing hope to cancer patients and physicians who treat them.


Showing results

110 of 3327

close
1.11181